Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Spyre Therapeutics Insider Sold Shares Worth $2,480,529, According to a Recent SEC Filing

Spyre Therapeutics Insider Sold Shares Worth $2,480,529, According to a Recent SEC Filing

MT newswireMT newswire2026/09/04 07:41
03:41 AM EDT, 09/04/2026 (MT Newswires) -- Heidy King-Jones, Chief Legal Officer and Corporate Secretary, on September 01, 2026, sold 28,399 shares in Spyre Therapeutics (SYRE) for $2,480,529. Following the Form 4 filing with the SEC, King-Jones has control over a total of 2,845 common shares of the company, with 2,845 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000111/xslF345X05/wk-form4_1788485651.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!